NCT06833840View on ClinicalTrials.gov

Evaluation of the Expression and Prognostic Role of Tumor Stem Cell Marker SOX2 in Odontogenic Cysts and Tumors

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

March 30, 2023

Study Completion Date

December 30, 2023

Conditions
Odontogenic CystsOdontogenic Tumors
Trial Locations (1)

12345

Faculty of Dentistry, Mansoura University, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER